A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2 (2020)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers12030533
PubMed Identifier: 32110852
Publication URI: http://europepmc.org/abstract/MED/32110852
Type: Journal Article/Review
Parent Publication: Cancers
Issue: 3
ISSN: 2072-6694